Evolution of therapeutic paradigms in Hodgkin lymphoma: from "cure-oriented" to "functional cure".

Front Oncol · 2026 · PMC13259688 · PMID 42294290

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While overall differences in progression-free survival compared with ABVD did not reach statistical significance, BV-AVD demonstrated higher early PET negativity rates and notable benefits in high-risk subgroups, particularly those with elevated baseline metabolic tumour volume ( 54 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.